UK markets closed
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • FTSE 250

    20,910.37
    -287.75 (-1.36%)
     
  • AIM

    1,183.25
    -8.61 (-0.72%)
     
  • GBP/EUR

    1.1537
    +0.0039 (+0.34%)
     
  • GBP/USD

    1.3921
    -0.0091 (-0.65%)
     
  • BTC-GBP

    33,859.25
    -353.62 (-1.03%)
     
  • CMC Crypto 200

    912.88
    -20.25 (-2.17%)
     
  • S&P 500

    3,811.15
    -18.19 (-0.48%)
     
  • DOW

    30,932.37
    -469.64 (-1.50%)
     
  • CRUDE OIL

    61.66
    -1.87 (-2.94%)
     
  • GOLD FUTURES

    1,733.00
    -42.40 (-2.39%)
     
  • NIKKEI 225

    28,966.01
    -1,202.26 (-3.99%)
     
  • HANG SENG

    28,980.21
    -1,093.96 (-3.64%)
     
  • DAX

    13,786.29
    -93.04 (-0.67%)
     
  • CAC 40

    5,703.22
    -80.67 (-1.39%)
     

Global Addictions Therapeutics Market Forecast to 2027 - COVID-19 Impacts & Analysis by Treatment Type, Drug Type, Treatment Center - ResearchAndMarkets.com

·2-min read

The "Addictions Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Treatment Type; Drug Type; Treatment Center; Distribution Channel and Geography" report has been added to ResearchAndMarkets.com's offering.

The market was valued at US$ 6,691.01 million in 2019 and is projected to reach US$ 10,735.94 million by 2027, it is expected to grow at a CAGR of 6.2% from 2020 to 2027.

Nicotine Addiction Treatment Segment to Register Highest CAGR in Addictions Therapeutics Market during 2020-2027.

Based on treatment type, the global addictions therapeutics market is segmented into nicotine addiction treatment, alcohol addiction treatment, opioid addiction treatment, and other substance addiction treatment. The nicotine addiction treatment segment held the largest share of the market in 2019.

Also, the same segment is estimated to register the highest CAGR in the market during the forecast period. The market growth for this segment is attributed to the increasing consumption of cigarette and tobacco products. As per the WHO, tobacco consumption is adversely affecting ~people's health, which creates substantial burden on healthcare facilities

In North America, the US is the most affected country due to the pandemic of the COVID-19 outbreak. The country has marked the highest number of COVID-19 positive cases. Across the nation, various healthcare research centers are working on the COVID-19 therapeutics. The demand for addictions therapeutics is reduced due to lockdown and supply chain disruptions across the region, which hinders the growth of the addictions therapeutics market.

The addictions therapeutics market growth is attributed to rising addiction among the general populace and increasing awareness campaigns. However, the steep costs of drug development hinder the market growth.

Cipla Ltd, Indivior Plc, Pfizer Inc, Orexo Ab, Glaxosmithkline Plc, Purdue Pharma L.P, Alvogen, Bausch Health, Camurus Ab, and Hikma Pharmaceuticals Plc are among the companies operating in the global addictions therapeutics market.

Key Market Dynamics

Market Drivers

  • Rising Addiction Among General Populace

  • Conduction of Awareness Campaigns

Market Restraint

  • Steeping Costs of Drug Development

Market Opportunity

  • Rising Demand for R&D from Contract Organizations

Future Trend

  • Consistent Launch of Therapeutics

Companies Mentioned

  • Cipla Ltd

  • Indivior Plc

  • Pfizer Inc

  • Orexo Ab,

  • Glaxosmithkline Plc

  • Purdue Pharma L.P

  • Alvogen

  • Bausch Health

  • Camurus Ab

  • Hikma Pharmaceuticals Plc

For more information about this report visit https://www.researchandmarkets.com/r/jdhcg6

View source version on businesswire.com: https://www.businesswire.com/news/home/20210126005632/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900